Estimating severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence from residual clinical blood samples, January-March 2021

• मुख्य लेखकों: Daniel S. Graciaa (लेखक), Hans P. Verkerke (लेखक), Jeannette Guarner (लेखक), Ana Maria Moldoveanu (लेखक), Narayanaiah Cheedarla (लेखक), Connie M. Arthur (लेखक), Cheryl L. Maier (लेखक), Andrew Neish (लेखक), Sara C. Auld (लेखक), Angie Campbell (लेखक), Neel R. Gandhi (लेखक), John D. Roback (लेखक), N. Sarita Shah (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Cambridge University Press, 2022-01-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

We describe severe acute respiratory coronavirus virus 2 (SARS-CoV-2) IgG seroprevalence and antigenemia among patients at a medical center in January-March 2021 using residual clinical blood samples. The overall seroprevalences were 17% by infection and 16% by vaccination. Spent or residual samples...